FDA Advisors Recommend Against Using MDMA for PTSD Treatment

A panel of experts advising the U.S. Food and Drug Administration (FDA) voted against adopting MDMA as a treatment for post-traumatic stress disorder (PTSD) on Tuesday. Members of the FDA’s Psychopharmacologic Drugs Advisory Committee said that they did not feel there is sufficient evidence to show that the drug is effective in a 9-2 vote. … Read more